Get the App
A

Avadel Pharmaceuticals-adr (AVDL)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Avadel Pharmaceuticals-adr (AVDL)

Avadel Pharmaceuticals plc is a biopharmaceutical company. The Company’s lead product candidate, FT218, is an investigational once-nightly formulation of sodium oxybate for the treatment of excessive daytime sleepiness (EDS), and cataplexy in narcole... Read more

  • 9.21
  • 9.21
  • 8.42
  • 10.02
  • 37.5%
  • --
  • 879.14k
  • 911.78k
  • 573M
  • 1.05
  • 8.9%
  • %

Stock News

The Moneyist: ‘This guy grifted me hard’: My date chose an exclusive L.A. restaurant. After dinner, he accepted my credit card — and we split a $600 bill. Shouldn’t he have paid?

1 hour ago

The Moneyist: ‘This guy grifted me hard’: My date chose an exclusive L.A. restaurant. After dinner, he accepted my credit card — and we split a $600 bill. Shouldn’t he have paid?

MarketWatch

Retire Better: This one great idea can make everyone better with money, older Americans say

1 hour ago

Retire Better: This one great idea can make everyone better with money, older Americans say

MarketWatch

These Are the 89 Best Restaurants in California, Says Michelin Guide

2 hours ago

These Are the 89 Best Restaurants in California, Says Michelin Guide

Bloomberg

Dow Jones Newswires: Australia’s central bank raises rates, says path to soft landing is narrow

2 hours ago

Dow Jones Newswires: Australia’s central bank raises rates, says path to soft landing is narrow

MarketWatch

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.

Try Premium